The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort

Hypertension

Volumn 29, Issue 2, 1997, Pages 628-633

  Schunkert, Heribert ^b   Hense, Hans Werner ^c   Gimenez Roqueplo, AnnePaule ^a   Stieber, Jutta ^c   Keil, Ulrich ^c   Riegger, Günter A J ^c   Jeunemaitre, Xavier ^a  

^a HÔPITAL BROUSSAIS   (France)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c NONE

Author keywords

angiotensinogen; antihypertensive agents; genetics; genotype; hypertension, essential

Indexed keywords

ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT;

ADULT; ALLELE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CORRELATION FUNCTION; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0031028894     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.2.628     Document Type: Article

References (31)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
2. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke and coronary heart disease, part 2: short term relations in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827-838.
3. Klag MJ, Whelton PK, Randall BL, Neaton J, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end stage renal disease in men. N Engl J Med. 1996;334:13-18.
4. Menard J, Cornu P, Day M. Cost of hypertension treatment and the price of health. J Hum Hypertens. 1992;6:447-458.
5. Hense HW, Tennis P. Changing patterns of antihypertensive drug use in a German population in 1984 and 1987. Eur J Clin Pharmacol. 1990;39:1-7.
6. Laragh JH, Baer L, Brunner HR, Bühler HR, Sealey JE, Vaughan ED. Renin, angiotensin, and aldosterone system in the pathogenesis and management of hypertensive vascular disease. Am J Med. 1972; 52:633-652.
7. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
8. Walker WG, Welton PK, Saito H, Rusell RP, Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1979;1:287-291.
9. Fasola AF, Martz BL, Helmer OM. Plasma renin activity during supine exercise in offspring of hypertensive parents. J Appl Physiol. 1968;25:410-415.
10. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edwards HV, Davidson HR, Connor JM, Lever AF, Fraser R. Abnormalities of glucocorticoid metabolism and the renin angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992;10:473-482.
11. Bloem LJ, Manatung AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995;95:948-953.
12. Caulfield M, Lavender P, Farall M, Munroe P, Lawson M, Turner P, Clark AJL. Linkage of the angiotensinogen gene to human essential hypertension. N Engl J Med. 1994;330:1629-1633.
13. Schmidt S, Sharma AM, Zilch O, Beige J, Walla-Friedel M, Ganten D, Distler A, Ritz E. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant. 1995;10:1145-1148.
14. Caulfield M, Lavender P, Newell-Price J, Farall M, Kamdar S, Daniel H, Lawson M, DeFreitas P, Fogarty P, Clark AJL. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest. 1995;96:687-692.
15. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 1994;93:1285-1287.
16. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension. 1995; 25:688-693.
17. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, Evans A, Nicaud V, Cambien F. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens. 1995;13:311-317.
18. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the angiotensin gene associated with variation in blood pressure in a genetic isolate. Circulation. 1994;90:2207-2212.
19. Keil U, Stieber J, Döring A, Härtel U, Filipatrik B, Hense HW. The cardiovascular risk profile in the study area Augsburg: results from the first MONICA survey 1984/1985. Acta Med Scand. 1988; 728(suppl):119-128.
20. Schunkert H, Ingelfinger JR, Hirsch AT, Tang SS, Litwin S, Talness C, Dzau VJ. Evidence for tissue specific activation of renal angiotensinogen mRNA expression in chronic stable heart failure. J Clin Invest. 1992;90:1523-1529.
21. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99:325-332.
22. Hassager C, Riis BJ, Strom V, Guyene TT, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation. 1987;76:753-758.
23. Schunkert H, Muscholl M, Luchner A, Riegger GAJ. Effects of estrogen replacement therapy on the renin angiotensin system in post-menopausal women. Circulation. 1997;95:39-45.
24. Schunkert H, Hense HW, Muscholl M, Luchner A, Riegger GAJ. Association of angiofensin convening enzyme activity and arterial blood pressure in a population based sample. J Hypertens. 1996; 14:571-575.
25. Gould AB, Green B. Kinetics of the human renin and human renin substrate reaction. Cardiovasc Res. 1971;5:86-89.
26. Manttari M, Tenkanen L, Manninen V, Alikoski T, Frick MH. Antihypertensive therapy in dyslipidemic men: effects on coronary heart disease incidence and total mortality. Hypertension. 1995;25:47-52.
27. Samuelsson O, Wilhelmsen L, Pennert K, Berglund G. Prognostic factors in treated hypertension. J Hypertens. 1985;3(suppl 3): S497-S500.
28. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 1995;345:1600-1603.
29. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995;92:2735-2739.
30. Morise T, Takeuchi Y, Takeda R. Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. J Intern Med. 1995;237:175-180.
31. Dudley C, Keavney B, Casadai B, Conway J, Bird R, Ratcliffe P. Prediction of patient responses to antihypertensive drug therapy using genetic polymorphisms: investigation of renin angiotensin system genes. J Hypertens. 1996;14:259-262.